RenovoRx appoints Richard Stark to its board and grants him $120,000 in options
RenovoRx appointed Richard Stark as a member of its board of directors effective November 18, 2026, according to an 8-K filing with the SEC. The board grew from six to seven members and determined that Stark qualifies as an independent director. He received 128,824 options valued at $120,000, with an exercise price of $1.12 and a 10-year term, plus an annual cash retainer of $40,000.
In 35 seconds
- Richard Stark joins RenovoRx's board effective November 18, 2026, and the board grows from six to seven members.
- He received 128,824 options valued at $120,000, with an exercise price of $1.12 and a 10-year term.
- The options vest monthly over 36 months, with full vesting in the event of a change of control.
IASummary generated by artificial intelligence from a story by TradingView. It may contain errors: the original source prevails.




Comments
Be respectful. Comments reported by several people are hidden until a moderator reviews them.
You do not need an account to read, only to comment. Sign in with a code sent to your email or with your Google account. We only show the name you choose, never your email.